JPRN-jRCTs031180413已完成未知
Third line H. pylori eradication therapy with sitafloxacin, amoxicillin and vonaprazan - Third line H. pylori eradication therapy with sitafloxacin, amoxicillin and vonaprazan
Hirata Kenro0 个研究点目标入组 75 人开始时间: 2019年3月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 75
研究概览
简要总结
Sitafloxacin-amoxicillin-vonaprazan 7day regimen was effective and safe as a third- or later-line H. pylori eradication regimen.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •H. pylori-positve patients after the 2nd line H. pylori eradication therapy with informed consent.
排除标准
- •1. Patients with allergy for quinolones
- •2. Patients with allergy for PPIs
- •3. Patients with severe liver injury and/or severe renal damage
- •4. Pregnancy or possible pregnancy
- •5. Patients who were recognized as inappropriate for entry
研究者
相似试验
已完成
2 期
Third-line H. pylori eradication therapy with sitafloxacin-including regimePatients with H. pylori eradication failure after the second-line regimenJPRN-UMIN000001558DIvision of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine30
已完成
不适用
The efficacy of third or fourth line H. pylori eradication therapy with refabutin-amoxicillin-vonaprazan 7day regimeA498Helicobacter pylori infectionJPRN-jRCTs031180362Hirata Kenro57
已完成
4 期
Evaluation of third-line eradication for H. pylori infection in JapaThe patients after unseccessful 1st and 2nd line eradicationtreatmentJPRN-UMIN000007632Japan Gast Study Group150
已完成
4 期
Vonoprazan-Based Triple Therapy in Comparison With Extended Sequential TherapyHelicobacter PyloriNCT05371249Fu Jen Catholic University Hospital628
已完成
不适用
A retrospective study in clinical course of Heicobacter pylori eradication therapyH.pylori infected patientsJPRN-UMIN000032351Asahikawa Medical University427